|
C14ORF118 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.212900E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.748200E-02 |
| Normal-vs-Stage2 |
1.034360E-01 |
| Normal-vs-Stage3 |
1.4919000002056E-07 |
| Normal-vs-Stage4 |
1.659800E-01 |
| Stage1-vs-Stage2 |
5.286200E-01 |
| Stage1-vs-Stage3 |
2.599900E-04 |
| Stage1-vs-Stage4 |
4.695000E-01 |
| Stage2-vs-Stage3 |
8.574300E-02 |
| Stage2-vs-Stage4 |
7.475600E-01 |
| Stage3-vs-Stage4 |
4.525400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.633800E-04 |
| Normal-vs-AfricanAmerican |
5.226200E-02 |
| Normal-vs-Asian |
4.152400E-01 |
| Caucasian-vs-AfricanAmerican |
9.742400E-01 |
| Caucasian-vs-Asian |
1.602050E-01 |
| AfricanAmerican-vs-Asian |
1.164790E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.083700E-03 |
| Normal-vs-Female |
5.701500E-03 |
| Male-vs-Female |
6.453400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
7.450300E-02 |
| Normal-vs-Age(41-60Yrs) |
3.040800E-01 |
| Normal-vs-Age(61-80Yrs) |
8.73920000032946E-07 |
| Normal-vs-Age(81-100Yrs) |
1.153800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.840200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.185000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.031400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.016500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.592000E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.009600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.294000E-01 |
| Normal-vs-Grade 2 |
1.852040E-02 |
| Normal-vs-Grade 3 |
1.68230999999519E-05 |
| Normal-vs-Grade 4 |
1.582590E-01 |
| Grade 1-vs-Grade 2 |
7.234000E-02 |
| Grade 1-vs-Grade 3 |
1.263950E-02 |
| Grade 1-vs-Grade 4 |
7.840500E-02 |
| Grade 2-vs-Grade 3 |
2.307700E-02 |
| Grade 2-vs-Grade 4 |
5.264400E-01 |
| Grade 3-vs-Grade 4 |
8.995800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
9.119000E-03 |
| Normal-vs-ccB subtype |
3.124400E-02 |
| ccA subtype-vs-ccB subtype |
8.958200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.261210E-01 |
| Normal-vs-N1 |
7.920400E-03 |
| N0-vs-N1 |
4.161600E-02 |
|
|
